跳至主要内容
临床试验/ACTRN12617000799358
ACTRN12617000799358招募中2 期

A randomised controlled clinical trial to evaluate the incidence and severity of oxygen desaturation events when using Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) to oxygenate paediatric patients undergoing microlaryngoscopy and bronchoscopy

Auckland District Health Board0 个研究点目标入组 250 人开始时间: 2017年5月31日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
250

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
o limit 至 13 Years(—)
性别
All

入选标准

  • The principal inclusion criteria are male and female patients under the age of 13 years who are undergoing Microlaryngoscopy and Bronchoscopy.

排除标准

  • Exclusion criteria are patients with a BMI (body mass index) greater than 35, severe nasal obstruction, patients with defects within the anterior skull base, inability to obtain informed parental consent, and emergency MLB when the time from being informed about the trial and time of surgery is less than 24 hours.
  • Children undergoing laser, diathermy or other forms of treatment associated with fires on or around their airway.

研究者

相似试验